Search research articles
Contact Us
Filters
Showing results (71-80 of 157) with videos related to
Page
of 16
Sort By:
Handbook of Experimental Pharmacology
|
February 6, 2017
Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance
Ulrike Taschler, Carina Hasenoehrl, Martin Storr, et al.
Zeitschrift Fur Gastroenterologie
|
February 8, 2021
[Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany]
Heiner Krammer, Martin Storr, Ahmed Madisch, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology
|
August 1, 2006
Enterothorax mimicking pleural effusion
Axel Ulsenheimer, Jörg Schirra, Burkhard Göke, et al.
Current Drug Targets
|
June 19, 2013
Nociceptin / orphanin FQ (NOP) receptors as novel potential target in the treatment of gastrointestinal diseases
Marta Sobczak, Maciej Sałaga, Martin Storr, et al.
Current Drug Targets
|
December 30, 2017
Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review
Agata Binienda, Martin Storr, Jakub Fichna, et al.
Neurogastroenterology and Motility
|
December 15, 2018
Enkephalinase inhibitors, potential therapeutics for the future treatment of diarrhea predominant functional gastrointestinal disorders
Agata Szymaszkiewicz, Martin Storr, Jakub Fichna, et al.
Inflammatory Bowel Diseases
|
March 31, 2015
Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease
Andrzej Wasilewski, Marta Zielińska, Martin Storr, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
January 29, 2016
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives
Maciej Salaga, Martin Storr, Kirill A Martemyanov, et al.
Therapeutics and Clinical Risk Management
|
June 4, 2016
Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
Aleksandra Sobolewska-Włodarczyk, Marcin Włodarczyk, Martin Storr, et al.
Journal of Clinical Medicine
|
November 11, 2022
Self-Medication for the Treatment of Abdominal Cramps and Pain-A Real-Life Comparison of Three Frequently Used Preparations
Martin Storr, Harald Weigmann, Sabine Landes, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 157) with videos related to
Sort By:
Page
of 16
Handbook of Experimental Pharmacology
|
February 6, 2017
Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance
Ulrike Taschler, Carina Hasenoehrl, Martin Storr, et al.
Zeitschrift Fur Gastroenterologie
|
February 8, 2021
[Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany]
Heiner Krammer, Martin Storr, Ahmed Madisch, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology
|
August 1, 2006
Enterothorax mimicking pleural effusion
Axel Ulsenheimer, Jörg Schirra, Burkhard Göke, et al.
Current Drug Targets
|
June 19, 2013
Nociceptin / orphanin FQ (NOP) receptors as novel potential target in the treatment of gastrointestinal diseases
Marta Sobczak, Maciej Sałaga, Martin Storr, et al.
Current Drug Targets
|
December 30, 2017
Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review
Agata Binienda, Martin Storr, Jakub Fichna, et al.
Neurogastroenterology and Motility
|
December 15, 2018
Enkephalinase inhibitors, potential therapeutics for the future treatment of diarrhea predominant functional gastrointestinal disorders
Agata Szymaszkiewicz, Martin Storr, Jakub Fichna, et al.
Inflammatory Bowel Diseases
|
March 31, 2015
Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease
Andrzej Wasilewski, Marta Zielińska, Martin Storr, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
January 29, 2016
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives
Maciej Salaga, Martin Storr, Kirill A Martemyanov, et al.
Therapeutics and Clinical Risk Management
|
June 4, 2016
Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
Aleksandra Sobolewska-Włodarczyk, Marcin Włodarczyk, Martin Storr, et al.
Journal of Clinical Medicine
|
November 11, 2022
Self-Medication for the Treatment of Abdominal Cramps and Pain-A Real-Life Comparison of Three Frequently Used Preparations
Martin Storr, Harald Weigmann, Sabine Landes, et al.
Page
of 16